Enduring Material

Perspectives on Use of the COVID-19 Vaccines with Psoriatic Disease
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
 
 
National Psoriasis Foundation

6600 SW 92nd Ave., Suite 300
Portland, OR 97223-7195
General Information
Monday, January 11, 2021 - Saturday, January 14, 2023
National Psoriasis Foundation
Virtual Conference Room
Psound Bytes CME Podcast
National Psoriasis Foundation
Objectives
  • Better understand the emerging COVID-19 vaccines
  • Be updated on the current research related to COVID-19
Presentations and Speakers
Perspectives on Use of the COVID-19 Vaccines with Psoriatic Disease
  • Joel Gelfand, MD
  • Christopher Ritchlin, MD
Available Credits/Points
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • The National Psoriasis Foundation designates this enduring material for a maximum of 0.75 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Listen to NPF COVID-19 Task Force co-chairs, dermatologist Dr. Joel Gelfand, Director, Psoriasis and Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Co-Director, Psoriasis Center, University of Rochester Medical Center in New York provide an update on the COVID-19 pandemic and vaccination during this unprecedented time.
Disclosure Statements
NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.
Speakers:
Joel Gelfand, MD has disclosed a relevant financial relationship with a commercial interest in the last 12 months:
  • Bristol-Myers Squibb, Boehringer Ingelheim, GlaxoSmithKline, Janssen Biologics, Novartis Corp, Regeneron, UCB, and Sanofi and Pfizer Inc - Consulting
  • Eli Lilly and Company and Ortho Dermatologics - CME work related to psoriasis
  • Society for Investigative Dermatology - deputy editor for the Journal of Investigative Dermatology
  • Abbvie, Janssen, Novartis Corp, Sanofi, Celgene, OrthoDermatologics, and Pfizer Inc -
Christopher Ritchlin, MD has disclosed a relevant financial relationship with a commercial interest in the last 12 months:
  • AbbVie, Amgen, Janssen, Novartis, UCB, Boerhinger Ingelheim -
  • Amgen, UCB and Abbvie -
All of the relevant financial relationships listed for these individuals have been mitigated.

Accreditation Statement
  • The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
100 %
1/5/2021
Continue to Enduring Material